The average one-year price target for GT Biopharma (NasdaqCM:GTBP) has been revised to 153.00 / share. This is an increase of 2,900.00% from the prior estimate of 5.10 dated January 16, 2024. The ...
The average one-year price target for Goodyear Tire & Rubber (NASDAQ:GT) has been revised to 16.66 / share. This is an increase of 15.02% from the prior estimate of 14.48 dated October 31, 2023. The ...
Gain Therapeutics' GT-02287 shows promising efficacy and safety data, targeting both idiopathic and GBA1 Parkinson’s disease, with potential for substantial market impact and investor gains. The ...
[Carscoops] RS3 prototype spotted at Nürburgring, Germany with aggressive aero upgrades 2.5-liter five-cylinder turbo engine reaches its final evolution, targeting AMG A45-level performance Limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback